KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Shares Issued: 2020-2024

Historic Shares Issued for AbCellera Biologics (ABCL) over the last 4 years, with Sep 2024 value amounting to $227,000.

  • AbCellera Biologics' Shares Issued fell 11.33% to $227,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.8 million, marking a year-over-year decrease of 36.99%. This contributed to the annual value of $4.6 million for FY2021, which is 99.12% down from last year.
  • AbCellera Biologics' Shares Issued amounted to $227,000 in Q3 2024, which was down 50.76% from $461,000 recorded in Q2 2024.
  • AbCellera Biologics' Shares Issued's 5-year high stood at $521.9 million during Q4 2020, with a 5-year trough of $124,000 in Q1 2020.
  • Moreover, its 2-year median value for Shares Issued was $397,500 (2023), whereas its average is $443,333.
  • The largest annual percentage gain for AbCellera Biologics' Shares Issued in the last 5 years was 1,246.46% (2021), contrasted with its biggest fall of 99.65% (2021).
  • AbCellera Biologics' Shares Issued (Quarterly) stood at $521.9 million in 2020, then plummeted by 99.65% to $1.8 million in 2021, then reached $256,000 in 2023, then decreased by 11.33% to $227,000 in 2024.
  • Its Shares Issued was $227,000 in Q3 2024, compared to $461,000 in Q2 2024 and $892,000 in Q1 2024.